Growth hormone-induced production of cytokines in murine peritoneal macrophages in vitro: Role of JAK/STAT, PI3K, PKC and MAP kinases

Immunobiology

Volumn 214, Issue 6, 2009, Pages 430-440

  Tripathi, Anurag ^a   Sodhi, Ajit ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Cytokines; ERK1 2; Growth hormone; JNK MAP kinase; Macrophage; Tyrosine kinases

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GROWTH HORMONE; INTERLEUKIN 12; INTERLEUKIN 1BETA; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE C; STAT PROTEIN; STAT1 PROTEIN; TRANSCRIPTION FACTOR ELK 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HORMONE ACTION; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELLS, CULTURED; CYTOKINES; ETS-DOMAIN PROTEIN ELK-1; GROWTH HORMONE; JANUS KINASE 2; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION;

EID: 64649104786     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2008.11.013     Document Type: Article

References (37)

1. Adams D.O., and Hamilton T.A. The cell biology of macrophages activation. Ann. Rev. Immunol. 2 (1984) 283-318
2. Anderson N.G. Growth hormone activates mitogen-activated protein kinase and S6 kinase and promotes intracellular tyrosine phosphorylation in 3T3-F442A preadipocytes. Biochem. J. 284 (1992) 649-652
3. Argetsinger L.S., Campbell G.S., Yang X., Witthuhn B.A., Silvennoinen O., Ihle J.N., and Carter-Su C. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74 (1993) 237-244
4. Campbell G.S., Christian L.J., and Carter-Su C. Evidence for involvement of the growth hormone receptor-associated tyrosine kinase in actions of growth hormone. J. Biol. Chem. 268 10 (1993) 7427-7434
5. Chappel S. Growth hormone in immune reconstitution. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 20 (1999) 423-431
6. Cook D.N., Pisetsky D.S., and Schwartz D.A. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5 (2004) 975-979
7. Gala R.R. Prolactin and growth hormone in the regulation of the immune system. Proc. Soc. Exp. Biol. Med. 198 (1991) 513-527
8. Germain R.N., and Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Ann. Rev. Immunol. 11 (1993) 403-490
9. Han Y.D., Leaman W., Watling D., Rogers N.C., Groner B., Kerr I.M., Wood W.I., and Stark G.R. Participation of JAK and STAT proteins in growth hormone-induced signaling. J. Biol. Chem. 271 (1996) 5947-5952
10. Hobbie S., Chen L.M., Davis R.J., and Galan J.E. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J. Immunol. 159 11 (1997) 5550-5559
11. Hommes D.W., Peppelenbosch M.P., and van Deventer S.J.H. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 52 (2003) 144-151
12. Hooghe-Peters E.L., and Hooghe R. Growth Hormone, Prolactin, and IGF-I as Lymphohematopoietic. Cytokines (1995), Austin/Springer, New York
13. Kao T.L., Supowit S.C., Thompson E.A., and Meyer III W.J. Immunoreactive growth hormone production by human lymphocyte cell. Cell Mol. Neurobiol. 12 (1992) 483-498
14. Kelley K.W., Brief S., Westly H.J., Novakofski J., Bechtel P.J., Simon J., and Walker E.B. GH3, pituitary adenoma cells can reverse thymic aging in rats. Proc. Natl. Acad. Sci. USA 83 (1986) 5663-5667
15. Klostergaard J., Stoltje P.A., and Kull Jr. F.C. Tumoricidal effector mechanisms of murine BCG-activated macrophages: role of TNF in conjugation-dependent and conjugation-independent pathways. J. Leuk. Biol. 48 (1990) 220-228
16. Kooijman R., Hooghe-Peters E.L., and Hooghe R. Prolactin, growth hormone and insulin-like growth factor-1 in the immune system. Adv. Immunol. 63 (1996) 377-453
17. Kopchick J.J., and Andry J.M. Growth hormone (GH), GH receptor, and signal transduction. Molecular genetics and metabolism. Mol. Genet. Metab. 71 (2000) 293-314
18. Lytras A., Quan N., Vrontakis M.E., Shaw J.E., Cattini P.A., and Friesen H.G. Growth hormone expression in human Burkitt lymphoma serum-free Ramos cell line. Endocrinology 132 (1993) 620-628
19. Malemud C.J. Growth hormone, VEGF and FGF: involvement in rheumatoid arthritis. Clin. Chem. Acta 375 1-2 (2007) 10-19
20. Martin G.S., Mannino D.M., Eaton S., Moss M., and Engl. N. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. J. Med. 348 (2003) 1546-1554
21. Mizel S.B. Interleukin 1 and T cell activation. Immunol. Rev. 36 (1982) 51-56
22. Murphy W.J., Durum S.K., and Longo D.L. Differential effects of growth hormone and prolactin on murine T cell development and function. J. Exp. Med. 178 (1993) 231-236
23. Murray H.W. Interferon-γ, the activated macrophage, and host defense against microbial challenge. Ann. Int. Med. 108 (1988) 595-608
24. Nathan C.F. Secretory products of macrophages. J. Clin. Invest. 79 (1987) 319-326
25. Nathan C.F., Prendergast T.J., Wiebe M.E., Stanley E.R., Platzer E., Remold H.G., Welte K., Rubin B.Y., and Murray H.W. Activation of human macrophages: comparison of other cytokines with interferon-γ. J. Exp. Med. 160 (1984) 600-605
26. Rothe J., Lesslauer W., Lotscher H., Lang Y., Koebel P., Kontgen A.F., Althage A., Zinkernagel R., Steinmetz M., and Bluethmann H. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364 (1993) 798-802
27. 2+ and nitric oxide dependent cytotoxicity. Mol. Immunol. 44 9 (2007) 2265-2267
28. Sodhi A., and Tripathi A. Prolactin and growth hormone induce differential cytokine and chemokine profile in murine peritoneal macrophages in vitro: involvement of p-38 MAP kinase, STAT3 and NF-κB. Cytokine 41 2 (2008) 162-173
29. Sodhi A., Singh R.K., and Singh S.M. Effect of IFN priming of murine peritoneal macrophages on the activation of tumoricidal state by IL-1, TNF and cisplatin. Clin. Exp. Immunol. 888 (1992) 350-355
30. Smit L.S., Meyer D.J., Argetsinger L.S., Schwartz J., and Carter-Su C. In: Kostyo J.L. (Ed). Handbook of Physiology (1999), Oxford University Press, New York 445-480
31. Stuehr D.J., and Nathan C.F. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169 (1989) 1543-1555
32. ++, and MAP kinase signal transduction pathways. Mol. Immunol. 44 (2007) 3185-3194
33. Tripathi A., and Sodhi A. Prolactin induced production of cytokines involves Jak/Stat and JNK MAP kinase pathways. Int. Immunol. 20 3 (2008) 327-336
34. 2. J. Immunol. 154 4 (1995) 1909-1918
35. Weigent D.A. Immunoregulatory properties of growth hormone and prolactin. J. Pharmacol. Therapeut. 69 (1996) 237-257
36. Weigent D.A., Baxter J.B., Wear W.E., Smith L.R., Bost K.L., and Blalock J.E. Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J. 2 (1988) 2812-2818
37. Xu B.C., Wang X., Darus C.J., and Kopchick J.J. Growth hormone promotes the association of transcription factor STAT5 with the growth hormone receptor. J. Biol. Chem. 271 (1996) 19768-19773